AG
RARE icon

Algert Global’s Ultragenyx Pharmaceutical RARE Stock Holding History

Algert Global’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.98M Buy
428,529
+209,297
+95% +$4.71M 0.14% 238
2025
Q4 		$5.04M Sell
219,232
-102,401
-32% -$3.37M 0.08% 432
2025
Q3 		$9.68M Buy
321,633
+205,286
+176% +$6.16M 0.16% 197
2025
Q2 		$4.23M Sell
116,347
-13,973
-11% -$504K 0.09% 385
2025
Q1 		$4.72M Buy
130,320
+47,527
+57% +$1.98M 0.12% 295
2024
Q4 		$3.48M Buy
82,793
+8,891
+12% +$441K 0.08% 411
2024
Q3 		$4.11M Buy
73,902
+23,580
+47% +$1.2M 0.11% 321
2024
Q2 		$2.07M Buy
50,322
+25,752
+105% +$1.1M 0.07% 457
2024
Q1 		$1.15M Hold
24,570
– – 0.04% 580
2023
Q4 		$1.18M Buy
24,570
+2,430
+11% +$94.2K 0.05% 577
2023
Q3 		$789K Sell
22,140
-4,710
-18% -$187K 0.04% 618
2023
Q2 		$1.24M Sell
26,850
-11,910
-31% -$552K 0.05% 578
2023
Q1 		$1.55M Buy
+38,760
New +$1.66M 0.07% 431
2022
Q2 		– Sell
-3,061
Closed -$222K – 1348
2022
Q1 		$222K Sell
3,061
-1,392
-31% -$96.9K 0.01% 1023
2021
Q4 		$374K Sell
4,453
-1,800
-29% -$146K 0.05% 650
2021
Q3 		$564K Buy
+6,253
New +$565K 0.08% 494

Other funds holding RARE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Algert Global's RARE Position: Q1 2026 in Review

Algert Global increased its Ultragenyx Pharmaceutical (RARE) stake by 95% in Q1 2026, buying an estimated $4.71M and bringing the position to 428,529 shares worth $8.98M. The position accounts for 0.14% of the portfolio, ranked #238.

Algert Global first reported a position in RARE in Q3 2021 and has held it in 16 quarters since. The position peaked at $9.68M in Q3 2025. 295 funds tracked by Wall St. Rank hold RARE as of Q1 2026.

  • Algert Global held 428,529 shares of Ultragenyx Pharmaceutical worth $8.98M as of Q1 2026.
  • Algert Global bought 209,297 Ultragenyx Pharmaceutical shares in Q1 2026, an estimated $4.71M.
  • Ultragenyx Pharmaceutical made up 0.14% of Algert Global's portfolio in Q1 2026, its #238 holding.
  • Algert Global first reported a position in Ultragenyx Pharmaceutical in Q3 2021 and has held it in 16 quarters since.
  • Algert Global's Ultragenyx Pharmaceutical position peaked at $9.68M in Q3 2025.
  • 295 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q1 2026.

Based on Algert Global's 13F filing for Q1 2026, filed 14 May 2026.